ABEIXI™
生化试剂
| PR-1414-L | HCV NS4 (1691-1710)(1712-1733)(1921-1940) mosaic 34 kDa |
| PR-1414-S | HCV NS4 (1691-1710)(1712-1733)(1921-1940) mosaic 34 kDa |
| PR-1416-L | HCV NS5 genotype 1b 38 kDa |
| PR-1416-S | HCV NS5 genotype 1b 38 kDa |
| PR-1417-L | HCV NS5 genotype 1a 37 kDa |
| PR-1417-S | HCV NS5 genotype 1a 37 kDa |
| PR-1418-L | HCV NS5 genotype 3a 36 kDa |
| PR-1418-S | HCV NS5 genotype 3a 36 kDa |
| PR-1419-L | HEV ORF2 44 kDa |
| PR-1419-S | HEV ORF2 44 kDa |
| PR-1420-L | HEV ORF2-ORF3 32 kDa |
| PR-1420-S | HEV ORF2-ORF3 32 kDa |
| PR-1421-L | Tp p17 137 kDa |
| PR-1421-S | Tp p17 137 kDa |
| PR-1422-L | Tp p41 153 kDa |
| PR-1422-S | Tp p41 153 kDa |
| PR-1423-L | Tp p47 164 kDa |
| PR-1423-S | Tp p47 164 kDa |
| PR-1424-L | Tp TmpA mosaic 32 kDa |
| PR-1424-S | Tp TmpA mosaic 32 kDa |
| PR-1425-L | Tp p15 13,3to17,9 kDa |
| PR-1425-S | Tp p15 13,3to17,9 kDa |
| PR-1426-L | Tp p17 21 kDa |
| PR-1426-S | Tp p17 21 kDa |
| PR-1427-L | Tp p41 45 kDa |
| PR-1427-S | Tp p41 45 kDa |
| PR-1428-L | Tp p47 47 kDa |
| PR-1428-S | Tp p47 47 kDa |
| PR-1429-L | HIV-1 M gp41 (537-811) 58 kDa |
| PR-1429-S | HIV-1 M gp41 (537-811) 58 kDa |
| PR-1430-L | HIV-1 M gp41 (542-674) 40 kDa |
| PR-1430-S | HIV-1 M gp41 (542-674) 40 kDa |
| PR-1431-L | HIV-2 gp36 (531-851) 62 kDa |
| PR-1431-S | HIV-2 gp36 (531-851) 62 kDa |
| PR-1432-L | HIV-1 M p24 52 kDa |
| PR-1432-S | HIV-1 M p24 52 kDa |
| PR-1433-L | HIV-2 gp36 (67-98) 36 kDa |
| PR-1433-S | HIV-2 gp36 (67-98) 36 kDa |
| PR-1434-L | HIV-1 M gp160 50 Kda |
| PR-1434-S | HIV-1 M gp160 50 Kda |
| PR-1435-L | HIV-1 M p31 36 kDa |
| PR-1435-S | HIV-1 M p31 36 kDa |
| PR-1436-L | HIV-1 M gp120 (v3 loop) 36 kDa |
| PR-1436-S | HIV-1 M gp120 (v3 loop) 36 kDa |
| PR-1437-L | HIV-1 O env mosaic 9 kDa |
| PR-1437-S | HIV-1 O env mosaic 9 kDa |
| PR-1438-L | HSV-1 gD 40 kDa |
| PR-1438-S | HSV-1 gD 40 kDa |
| PR-1439-L | HSV-2 gD 41 kDa |
| PR-1439-S | HSV-2 gD 41 kDa |
| PR-1440-L | HSV-2 gG. 33 kDa |
| PR-1440-S | HSV-2 gG. 33 kDa |
| PR-1441-L | HSV-1 gG 36 kDa |
| PR-1441-S | HSV-1 gG 36 kDa |
| PR-1442-L | CMV pp150 (UL32) 29 kDa |
| PR-1442-S | CMV pp150 (UL32) 29 kDa |
| PR-1443-L | CMV pp52 (UL44) 51 kDa |
| PR-1443-S | CMV pp52 (UL44) 51 kDa |
| PR-1444-L | CMV gB mosaic 39 kDa |
| PR-1444-S | CMV gB mosaic 39 kDa |
| PR-1445-L | Toxoplasma SAG1 48 kDa |
| PR-1445-S | Toxoplasma SAG1 48 kDa |
| PR-1446-L | EBV EBNA-3A 38 kDa |
| PR-1446-S | EBV EBNA-3A 38 kDa |
| PR-1447-L | EBV EBNA-1 mosaic 45 kDa |
| PR-1447-S | EBV EBNA-1 mosaic 45 kDa |
| PR-1448-L | EBV EA-D 35 kDa |
| PR-1448-S | EBV EA-D 35 kDa |
| PR-1449-L | EBV p18 38 kDa |
| PR-1449-S | EBV p18 38 kDa |
| PR-1450-L | TBEV gE 41 kDa |
| PR-1450-S | TBEV gE 41 kDa |
| PR-1451-L | Chlamydia MOMP 42 kDa |
| PR-1451-S | Chlamydia MOMP 42 kDa |
| PR-1452-L | SARS nucleocapsid |
| PR-1452-S | SARS nucleocapsid |
| PR-1453-L | SARS glycoprotein M |
| PR-1453-S | SARS glycoprotein M |
| PR-1454-L | SARS-CoV-2 – nucleocapsid protein – 48.3 kDa |
| PR-1454-S | SARS-CoV-2 – nucleocapsid protein – 48.3 kDa |
| PR-1455-L | SARS-CoV-2 – nucleocapsid protein – 40.6 kDa |
| PR-1455-S | SARS-CoV-2 – nucleocapsid protein – 40.6 kDa |
| PR-1456-L | SARS-CoV-2 – nucleocapsid protein – 62.2 kDa |
| PR-1456-S | SARS-CoV-2 – nucleocapsid protein – 62.2 kDa |
| PR-183 | Rab4B |
| PR-184 | Rab5A |
| PR-185 | Rab9 |
| PR-187 | Rab14 |
| PR-189 | Rab19 |
| PR-190 | Rab22A |
| PR-191 | Rab23 |
| PR-192 | Rab27 delta C26 |
| PR-193 | Rab31 |
| PR-194 | Rab32 |
| PR-196 | Rab37 |
| PR-202 | H-Ras ΔC (S17N) |
| PR-203 | H-Ras (Q61L) |
| PR-206 | H-Ras (G12V) |
| PR-212 | Ran – T24N |
| PR-215 | Ran – E70A |